EP1351573A4 - Methods for modulating tumor growth and metastasis - Google Patents
Methods for modulating tumor growth and metastasisInfo
- Publication number
- EP1351573A4 EP1351573A4 EP01994435A EP01994435A EP1351573A4 EP 1351573 A4 EP1351573 A4 EP 1351573A4 EP 01994435 A EP01994435 A EP 01994435A EP 01994435 A EP01994435 A EP 01994435A EP 1351573 A4 EP1351573 A4 EP 1351573A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- metastasis
- methods
- tumor growth
- modulating tumor
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25819500P | 2000-12-22 | 2000-12-22 | |
US258195P | 2000-12-22 | ||
PCT/US2001/050261 WO2002056692A1 (en) | 2000-12-22 | 2001-12-20 | Methods for modulating tumor growth and metastasis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1351573A1 EP1351573A1 (en) | 2003-10-15 |
EP1351573A4 true EP1351573A4 (en) | 2007-03-28 |
Family
ID=22979500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01994435A Withdrawn EP1351573A4 (en) | 2000-12-22 | 2001-12-20 | Methods for modulating tumor growth and metastasis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1351573A4 (en) |
JP (2) | JP2004523517A (en) |
AU (1) | AU2002246827B2 (en) |
CA (1) | CA2432792C (en) |
WO (1) | WO2002056692A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4470321B2 (en) | 1998-04-03 | 2010-06-02 | 味の素株式会社 | Antitumor agent |
JP2004517821A (en) | 2000-10-27 | 2004-06-17 | アベンティス・ファーマ・ソシエテ・アノニム | Combinations of camptothecin and stilbene derivatives for cancer treatment |
US20050209310A1 (en) * | 2000-12-22 | 2005-09-22 | Chaplin David J | Methods for modulating tumor growth and metastasis |
WO2002056692A1 (en) * | 2000-12-22 | 2002-07-25 | Bristol-Myers Squibb Company | Methods for modulating tumor growth and metastasis |
US20020183266A1 (en) * | 2001-03-15 | 2002-12-05 | Aventis Pharma, S.A. | Combination comprising combretastatin and anticancer agents |
JP2006503852A (en) * | 2002-09-25 | 2006-02-02 | ユニバーシティー オブ ロチェスター | Caspase inhibitors as anticancer drugs |
WO2004032947A1 (en) * | 2002-10-09 | 2004-04-22 | Unibioscreen S.A. | Extract with anti-tumor and anti-poisonous activity |
TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
EP2047858A1 (en) * | 2007-10-10 | 2009-04-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Combination products for treating cancer |
DK2219451T3 (en) * | 2007-11-21 | 2015-01-12 | Oxigene Inc | A method for the treatment of hematopoietic neoplasms |
US20090209496A1 (en) * | 2008-02-15 | 2009-08-20 | David Chaplin | Methods and compositions for enhancing the efficacy of rtk inhibitors |
FR2939665B1 (en) | 2008-12-12 | 2011-10-07 | Sanofi Aventis | ANTITUMOR COMBINATION ASSOCIATING WITH AVE8062A AND DOCETAXEL |
EP3337495A4 (en) | 2015-08-18 | 2019-04-10 | Mateon Therapeutics, Inc. | Use of vdas to enhance immunomodulating therapies against tumors |
CN107773556B (en) * | 2016-08-26 | 2020-08-18 | 广州安好医药科技有限公司 | Combined medicine with anti-tumor medicine efficacy |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048591A1 (en) * | 1999-02-16 | 2000-08-24 | Angiogene Pharmaceuticals Ltd. | Combinations for the treatment of diseases involving angiogenesis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996237A (en) | 1987-01-06 | 1991-02-26 | Arizona Board Of Regents | Combretastatin A-4 |
CA1338645C (en) | 1987-01-06 | 1996-10-15 | George R. Pettit | Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins" |
US5561122A (en) | 1994-12-22 | 1996-10-01 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Combretastatin A-4 prodrug |
WO1999035150A1 (en) | 1998-01-09 | 1999-07-15 | Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University | Synthesis of combretastatin a-4 prodrugs and trans-isomers thereo f |
AU776511B2 (en) | 1999-02-18 | 2004-09-09 | Baylor University | Compositions and methods for use in targeting vascular destruction |
WO2002056692A1 (en) * | 2000-12-22 | 2002-07-25 | Bristol-Myers Squibb Company | Methods for modulating tumor growth and metastasis |
-
2001
- 2001-12-20 WO PCT/US2001/050261 patent/WO2002056692A1/en active Application Filing
- 2001-12-20 EP EP01994435A patent/EP1351573A4/en not_active Withdrawn
- 2001-12-20 CA CA2432792A patent/CA2432792C/en not_active Expired - Fee Related
- 2001-12-20 AU AU2002246827A patent/AU2002246827B2/en not_active Ceased
- 2001-12-20 JP JP2002557211A patent/JP2004523517A/en active Pending
-
2008
- 2008-12-10 JP JP2008315096A patent/JP2009102350A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048591A1 (en) * | 1999-02-16 | 2000-08-24 | Angiogene Pharmaceuticals Ltd. | Combinations for the treatment of diseases involving angiogenesis |
Non-Patent Citations (5)
Title |
---|
CHAPLIN D J ET AL: "ANTI-VASCULAR APPROACHES TO SOLID TUMOUR THERAPY: EVALUATION OF COMBRETASTATIN A4 PHOSPHATE", ANTICANCER RESEARCH, HELENIC ANTICANCER INSTITUTE, ATHENS,, GR, vol. 19, no. 1A, January 1999 (1999-01-01), pages 189 - 196, XP008013078, ISSN: 0250-7005 * |
HORSMAN M R ET AL: "COMBRETASTATINS NOVEL VASCULAR TARGETING DRUGS FOR IMPROVING ANTI-CANCER THERAPY COMBRETASTATINS AND CONVENTIONAL THERAPY", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, SPRING ST., NY, US, vol. 476, 2000, pages 311 - 323, XP008013085, ISSN: 0065-2598 * |
LINGYUN LI, B.S. AND OTHERS: "Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS, vol. 42, no. 4, 1998, pages 899 - 903, XP002419739 * |
NELKIN B D ET AL: "COMBRETASTATIN A-4 AND DOXORUBICIN COMBINATION TREATMENT IF EFFECTIVE IN A PRECLINICAL MODEL OF HUMAN MEDULLARY THYROID CARCINOMA", ONCOLOGY REPORTS, NATIONAL HELLENIC RESEARCH FOUNDATION, ATHENS, GR, vol. 8, no. 1, January 2001 (2001-01-01), pages 157 - 160, XP008013083, ISSN: 1021-335X * |
See also references of WO02056692A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2009102350A (en) | 2009-05-14 |
WO2002056692A1 (en) | 2002-07-25 |
CA2432792C (en) | 2012-04-03 |
AU2002246827B2 (en) | 2008-02-21 |
EP1351573A1 (en) | 2003-10-15 |
CA2432792A1 (en) | 2002-07-25 |
JP2004523517A (en) | 2004-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5091201A (en) | Vegf-modulated genes and methods employing them | |
HK1067907A1 (en) | Amplifier modulation | |
HK1055287A1 (en) | Ferrite material | |
EP1351573A4 (en) | Methods for modulating tumor growth and metastasis | |
GB0008264D0 (en) | Novel method and compounds | |
EP1313477A4 (en) | Compounds and methods | |
IL158750A0 (en) | Reagents and methods for modulating dkk-mediated interactions | |
EP1274424A4 (en) | Compounds and methods | |
AU2140402A (en) | Human elongase genes uses thereof and compounds for modulating same | |
AU2001278338A1 (en) | Methods and compositions for modulating tumor growth | |
EP1267800A4 (en) | Methods of modulating hair growth | |
ZA200206318B (en) | Modulation of bone formation. | |
AU6174301A (en) | Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity | |
AU2002364612A8 (en) | Methods and materials for modulating enac-beta | |
GB0022617D0 (en) | Recording material and method | |
AU2002211359A1 (en) | Stem cell-based methods for preventing and treating tumor | |
AU6975001A (en) | Metalloprotease peptide substrates and methods | |
EP1343796A4 (en) | Compounds and methods | |
AU2635001A (en) | Polynucleotides for inhibiting metastasis and tumor cell growth | |
EP1287362A4 (en) | Compositions and methods for modulating tumor specific expression | |
AU3402001A (en) | Novel ligands and methods for preparing same | |
AU4949901A (en) | Methods for inhibiting angiogenesis and tumor growth | |
AU2001243495A1 (en) | Method for modulating tumor growth and metastasis of tumor cells | |
AU2002367320A8 (en) | Methods and materials for modulating task-3 | |
GB9816110D0 (en) | Planting medium and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030623 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 45/06 20060101AFI20070214BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20070222 |
|
17Q | First examination report despatched |
Effective date: 20071219 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130702 |